Skip to content

DRG International, Inc.

United Statesfrom the FDA registration address FDA establishment FEI 2245285

DRG International, Inc. is a medical device manufacturer, with 212 devices listed in FDA GUDID (FDA Class I and II) and 9 FDA recalls as of 21 Nov 2026.

Devices
212
Registrations
FDA
FDA recalls
96 ongoing

Registry facts

Counted by deviCERTS from registry records, 21 Nov 2026

Registries
  • FDA GUDID 212
Device classes
  • FDA Class I 106
  • FDA Class II 106
Identifiers
  • FDA FEI 2245285

What DRG International, Inc. makes

DRG International, Inc. manufactures in vitro diagnostic (IVD) enzyme immunoassay (EIA) kits for serum and plasma testing, including assays for thyroid markers (such as free thyroxine, free triiodothyronine, and thyroid antibodies), estradiol, luteinizing hormone, rheumatoid factor, anticardiolipin antibodies, and extractable nuclear antigens (ENA). Additional products cover vitamin D, Bordetella pertussis, Taenia Solium, varicella zoster virus, and testosterone measurements via ELISA formats.

The company’s portfolio includes devices classified as Class I and Class II under FDA regulations, all listed in the FDA’s Unique Device Identifier (UDI) database.

AI-generated from registry data, 26 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue212

Newest first, rows 1-50 of 212

Search and filter all 212 devices
Skip device list

Rows 1-50 of 212

Showing 1-50 of 212

Company details

FDA FEI number
2245285
Address
841 Mountain Ave, Springfield, NJ, 07081

FDA recalls9

Recalls are matched to the firm by name. FDA recall data as of 1 Nov 2026.

FDA recall records list 9 recalls initiated by DRG International, Inc., the earliest on 2009-11-09 and the most recent on 2026-07-02. By recorded status: 6 ongoing and 3 terminated. The reasons filed fall into these groups: labeling or instructions for use, performance or accuracy and manufacturing or quality process. A recall is often a precaution started by the manufacturer, and a count of records is not a verdict on a company.

Generated automatically from FDA recall records, as a summary of the records listed below. It describes what the records state and is not an assessment of this manufacturer.

Recalls initiated per year

  • 2017 0
  • 2018 0
  • 2019 0
  • 2020 0
  • 2021 2
  • 2022 0
  • 2023 0
  • 2024 3
  • 2025 1
  • 2026 1

2 initiated before 2017

  • 2026

    • 2 Jul 2026 Z-0082-2027 Class II Ongoing Potential for false negative patient results. Distribution: Worldwide - US Nationwide distribution in the state of NJ and the countries of Azerbaijan, Belgium, Czech Republic,…
      Full distribution text Worldwide - US Nationwide distribution in the state of NJ and the countries of Azerbaijan, Belgium, Czech Republic, Germany, Hungary, India, Italy, Kuwait, Russia, Spain, Ukraine.
  • 2025

    • 4 Jun 2025 Z-2265-2025 Class III Ongoing An incoming complaint reported that the expiration date on the kit box label and Certificate of Analysis (CoA) exceeded the shelf life of the standards and control solutions in the kit by 2 months (i.e., 2026-03-31 instead of 2026-01-31). The expiration dates on the bottle labels were correct (i.e., 2026-01-31). Distribution: Worldwide - US Nationwide distribution in the states of CA, MA, PA and the countries of Germany, Hong Kong, Moldova.
  • 2024

    • 7 Oct 2024 Z-0921-2025 Class II Ongoing The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument using the re-calibration R1 and R2 of the device or find controls out of specification (failed Control High) which causes a delay in results. Distribution: Worldwide - US Nationwide distribution in the state of New Jersey and the countries of Czechia and Romania.
    • 13 Sep 2024 Z-0258-2025 Class III Ongoing The High and Low Control acceptance ranges in the Certificate of Analysis (CofA) did not match the acceptance range information on the High and Low Control Component labels. Due to the defect, the device failed to provide results, which may result in a delay in obtaining test results and a remote chance of an adverse health risk. Distribution: AZ, CA, NH Foreign: Austria Belgium Georgia Germany Greece India Irak Italy Netherlands Poland Romania Russia Singapore…
      Full distribution text AZ, CA, NH Foreign: Austria Belgium Georgia Germany Greece India Irak Italy Netherlands Poland Romania Russia Singapore Spain Tunesia Vietnam
    • 5 Jul 2024 Z-2622-2024 Class III Ongoing Invalid Controls. The Low Control is out of range; too high which causes invalid runs that would result in repeating the runs and delays for reporting results to patients. Distribution: US Nationwide distribution in the states of CA, IL, MN, PA, UT, VA. Submission number: K052649
  • 2021

    • 21 Dec 2021 Z-0896-2022 Class II Terminated ODs of the standards too low(< 0.6 ODmax) may cause invalid runs, delayed patient results are possible Distribution: NY
    • 18 Oct 2021 Z-0310-2022 Class II Ongoing Firm has identified two lots of product that do not meet product shelf life, resulting in failed Controls. The clinical impact may be a delay in diagnosis and a consumption of patient samples. Distribution: Domestic: NY; International: TZ, VN, BD, CO, TT, YE, BO, DE, SV, GE, PY, TG, RU/UA, NI, DO, NG, EG & CM Submission number: K991432
  • 2009

    • 9 Nov 2009 Z-1067-2010 Unclassified (pre-2012) Terminated CHROMagar Products are labeled incorrectly. Label currently states that the product is for IVD use, when it should state that the product is intended For Research Use, Not for use in diagnostic procedures. Distribution: Nationwide distribution
    • 9 Nov 2009 Z-1068-2010 Unclassified (pre-2012) Terminated CHROMagar Products are labeled incorrectly. Label currently states that the product is for IVD use, when it should state that the product is intended For Research Use, Not for use in diagnostic procedures. Distribution: Nationwide distribution

Frequently asked questions

How many devices does DRG International, Inc. have in the registry?

The registry currently lists 212 devices for DRG International, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list DRG International, Inc.'s devices?

Among its 50 most recently registered devices, DRG International, Inc. has devices listed in FDA GUDID (50 devices).

What risk classes do DRG International, Inc.'s devices fall under?

Among its 50 most recently registered devices, the classes recorded for DRG International, Inc.'s devices are Class I and Class II. Each device page shows its own class and authorisation.

Are there FDA recall records for DRG International, Inc.?

FDA recall records list 9 recalls initiated by DRG International, Inc., the most recent initiated on 2 Jul 2026. 6 of them are recorded as ongoing. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.

What are the newest devices from DRG International, Inc. in the registry?

The most recently registered devices listed for DRG International, Inc. include 25 OH Vitamin D Total (90') ELISA EIA-6087, Bordetella pertussis IgG ELISA EIA-3450, Anti-dsDNA IgM ELISA EIA-3564 and Free Thyroxine (fT4) ELISA EIA-4266.

Generated automatically from registry data and not verified by a human reviewer.

This is an FDA establishment record. No EUDAMED registration is known for this company.